Fundamentals data is not available for this company.
| Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-25 | 629.11 | 60.33 | (1.86)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-26 | 744.84 | 140.94 | 30.46¢ | 46.8 | n/a | n/a | n/a | 0.0% |
| 31-Dec-27 | 883.69 | 238.49 | 58.88¢ | 24.2 | 0.3 | +93% | n/a | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
| BioMarin buys pharma peer Amicus for $4.8bn | 19-Dec-2025 | ShareCast |
| Currency | US Dollars |
| Share Price | $ 14.25 |
| Change Today | $ 0.04 |
| % Change | 0.28 % |
| 52 Week High | $14.26 |
| 52 Week Low | $5.73 |
| Volume | 5,937,321 |
| Shares Issued | 230.44m |
| Market Cap | $3,283.72m |
| RiskGrade | 552 |
| Strong Buy | 5 |
| Buy | 0 |
| Neutral | 3 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 8 |

You are here: research